AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Perspective Therapeutics, Inc. Director's Dealing 2012

Apr 23, 2012

33510_dirs_2012-04-23_a1a67b91-c76f-4bd7-a6ef-9b3f4ffbb130.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2011-11-17

Reporting Person: Babcock Dwight William (Director, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-11-17	Common Stock	P	2500	$0.77	Acquired	163773	Direct
2011-11-18	Common Stock	P	500	$0.83	Acquired	164273	Direct
2011-11-21	Common Stock	P	400	$0.84	Acquired	164673	Direct
2011-11-21	Common Stock	P	1100	$0.8499	Acquired	165773	Direct
2011-11-21	Common Stock	P	100	$0.85	Acquired	165873	Direct

Footnotes

F1: This amendment is being filed to correct the total securities beneficially owned in Column 5. No changes have been made to the reported purchases.